Testing the Combination of Copanlisib, Nivolumab and Ipilimumab in Patients With Advanced Cancer and Lymphoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
Pfizer
Essen Biotech
M.D. Anderson Cancer Center
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
Eli Lilly and Company
OncoNano Medicine, Inc.
Turning Point Therapeutics, Inc.
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
Cook Group Incorporated
Nurix Therapeutics, Inc.
Antengene Corporation
IGM Biosciences, Inc.